In Silico and In Vitro studies of taiwan chingguan yihau (NRICM101) on TNF-α/IL-1β-induced human lung cells

COVID-19 pandemic has been a global outbreak of coronavirus (SARS-CoV-2 virus) since 2019. Taiwan Chingguan Yihau (NRICM101) is the first traditional Chinese medicine (TCM) classic herbal formula and is widely used for COVID-19 patients in Taiwan and more than 50 nations. This study is to investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yih-Dih, Lu, Chi-Cheng, Hsu, Yuan-Man, Tsai, Fuu-Jen, Bau, Da-Tian, Tsai, Shih-Chang, Cheng, Ching-Chang, Lin, Jen-Jyh, Huang, Yuang-Yu, Juan, Yu-Ning, Chiu, Yu-Jen, Kuo, Sheng-Chu, Yang, Jai-Sing, Wu, Lii-Tzu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: China Medical University 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629402/
https://www.ncbi.nlm.nih.gov/pubmed/36381194
http://dx.doi.org/10.37796/2211-8039.1378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629402/
https://www.ncbi.nlm.nih.gov/pubmed/36381194
http://dx.doi.org/10.37796/2211-8039.1378

Ejemplares similares